Related Experiment Videos
Novel pharmacological agents in clinical development for solid tumours
1Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Abstract:
For decades, cancer therapy has focused on DNA-directed mechanisms of cytotoxicity, utilising agents with limited efficacy and significant toxicity. Recent advances in tumour biology have elucidated the molecular pathways implicated in the pathogenesis and progression of cancers and have resulted in the discovery of a variety of novel molecular targets for therapeutic intervention. Promising novel agents targeting signal transduction pathways, cell cycle regulation, angiogenesis and apoptosis are in clinical testing and are discussed in this review.
Insights
Traditional cancer treatments using DNA-damaging agents have limitations. Novel molecular targets and therapeutic agents are emerging, offering new hope for effective cancer treatment with reduced toxicity.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cancer therapy has historically relied on DNA-directed cytotoxic agents.
- These traditional methods often exhibit limited efficacy and substantial toxicity.
- Recent breakthroughs in tumor biology have identified novel molecular targets.
Purpose of the Study:
- To review recent advances in cancer therapy.
- To discuss novel molecular targets and therapeutic agents.
- To highlight agents targeting key cancer pathways currently in clinical trials.
Main Methods:
- Literature review of recent advances in cancer therapy.
- Analysis of novel molecular targets in cancer pathogenesis.
- Discussion of therapeutic agents targeting signal transduction, cell cycle, angiogenesis, and apoptosis.
Main Results:
- Identification of novel molecular targets in cancer progression.
- Emergence of promising therapeutic agents in clinical testing.
- Focus on targeted therapies with potentially improved efficacy and reduced toxicity.
Conclusions:
- Novel therapeutic strategies targeting specific molecular pathways represent a paradigm shift in cancer treatment.
- Targeted agents show promise for more effective and less toxic cancer therapies.
- The review highlights the potential of these new agents in clinical practice.